Sep 15, 2025
Medtronic Announces Pricing of €1.5 Billion of Senior Notes
Sep 02, 2025
FDA Clears MiniMed™ 780G System to Enable Integration with the Instinct Sensor, Made by Abbott, and Approves Use in Type 2 Diabetes
Aug 29, 2025
Medtronic executives to speak at upcoming investor conferences
Aug 19, 2025
Medtronic announces Board appointments and shareholder value creation initiatives to advance strategic priorities
Aug 19, 2025
Medtronic reports first quarter fiscal 2026 financial results
Aug 14, 2025
Medtronic announces cash dividend for second quarter of fiscal year 2026
Jul 21, 2025
Medtronic secures CE Mark for MiniMed(TM) 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes
Jul 08, 2025
Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company
May 21, 2025
Medtronic reports strong finish to its fiscal year with its fourth quarter financial results; announces dividend increase
May 21, 2025
Medtronic announces intent to separate Diabetes business
May 07, 2025
Medtronic to announce financial results for its fourth quarter and full fiscal year 2025
Apr 26, 2025
Medtronic Affera(TM) pulsed field ablation technologies continue to demonstrate promising evidence for atrial fibrillation patients
Apr 26, 2025
Medtronic Expand URO U.S. clinical trial meets safety and effectiveness primary endpoints for Hugo(TM) robotic-assisted surgery system
Apr 18, 2025
New Simplera Sync(TM) sensor for the MiniMed(TM) 780G System now FDA approved
Mar 30, 2025
Medtronic Evolut(TM) TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients
Mar 09, 2025
SMART Trial two-year data continues to demonstrate superior valve performance for Evolut TAVR(TM) system in small annulus patients
Mar 06, 2025
Medtronic announces cash dividend for fourth quarter of fiscal year 2025
Feb 24, 2025
Medtronic earns U.S. FDA approval for the world's first Adaptive deep brain stimulation system for people with Parkinson's
Feb 05, 2025
Medtronic to announce financial results for its third quarter of fiscal year 2025
Jan 21, 2025
Medtronic appoints Thierry Piéton as Chief Financial Officer